UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000017777 |
|---|---|
| Receipt number | R000020587 |
| Scientific Title | The study evaluating the efficacy and safety of sorafenib in patients with differentiated thyroid cancer not amendable to radioactive iodine therapy and other alternative treatment. |
| Date of disclosure of the study information | 2015/06/02 |
| Last modified on | 2019/03/07 16:53:59 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/06/02 18:32:29 | ||
| 2 | Update | 2015/11/27 19:58:03 | Recruitment status |
|
| 3 | Update | 2016/07/02 10:13:52 | Name of primary person or sponsor Institute Organization Organization |
|
| 4 | Update | 2016/07/02 10:14:38 | Recruitment status |
|
| 5 | Update | 2017/12/04 09:34:29 | Recruitment status Last follow-up date Date of closure to data entry |
|
| 6 | Update | 2018/05/30 14:52:41 | UMIN ID1 |
|
| 7 | Update | 2018/05/30 14:57:36 | Name of person sending information TEL |
|
| 8 | Update | 2018/05/30 15:00:00 | Name of person sending information |
|
| 9 | Update | 2019/03/07 16:31:38 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 10 | Update | 2019/03/07 16:53:59 | Recruitment status |
